505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA
Similar to 505(b)(2)
AACR - American Association for Cancer ResearchAADA - Abbreviated Antibiotic Drug Application
AAEP - American Association of Equine Practitioners
AAFCO - Association of American Feed Control Officials
AAFP - American Academy of Family Physicians
AAHA - American Animal Hospital Association
AAI - American Association of Immunologists
View all in FDA